Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
38.89
+1.16 (3.07%)
At close: Sep 11, 2026, 4:00 PM EDT
38.50
-0.39 (-1.00%)
After-hours: Sep 11, 2026, 7:55 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $5.23 billion as of September 11, 2026. Its market cap has increased by 636.09% in one year.
Market Cap
5.23B
Enterprise Value
4.18B
1-Year Change
636.09%
Ranking
Category
Stock Price
$38.89
ChartMarket Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $5.23B, an increase of 777.70%. That is a compound annual growth rate of 39.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 5.23B | 296.16% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 6.12B |
| Dianthus Therapeutics | 5.94B |
| Cogent Biosciences | 5.80B |
| Xenon Pharmaceuticals | 5.68B |
| Ligand Pharmaceuticals | 5.67B |
| Erasca | 5.55B |
| PTC Therapeutics | 5.51B |
| CRISPR Therapeutics AG | 5.00B |